Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion type Assertion NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_head.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion description "[The preclinical mutation carrier group 2 scored significantly higher than the nonmutation carrier group for 3 of the SCL-90-R symptom dimensions (anxiety, paranoid ideation, and psychoticism).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_provenance.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion evidence source_evidence_literature NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_provenance.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion SIO_000772 17210818 NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_provenance.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion wasDerivedFrom befree-2016 NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_provenance.
- NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_assertion wasGeneratedBy ECO_0000203 NP587788.RAzoUtimubc6ScVFj3s65j3_krYDMF2Hv34L4hzPzL-10130_provenance.